Sana Biotechnology, Inc. (SANA) Tops Q1 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth